文獻名:Graphene Oxide (GO)-based Nanosheets With Combined Chemo/photothermal/Photodynamic Therapy to Overcome Gastric Cancer (GC) Paclitaxel Resistance by Reducing Mitochondria-Derived Adenosine-Triphosphate (ATP)
作者: Weihong Guo, Zhian Chen, Xiaoli Feng, Guodong Shen, Huilin Huang, Yanrui Liang, Bingxia Zhao, Guoxin Li, Yanfeng Hu
Department of General Surgery, Nanfang Hospital, Southern Medical University
摘要:
Background
Paclitaxel (PTX) has been suggested to be a promising front-line drug for gastric cancer (GC), while Pglycoprotein (P-gp) could lead to drug resistance by pumping PTX out of GC cells. Consequently, it might be a hopeful way to combat drug resistance by inhibiting the out-pumping function of P-gp.
Results
In this study, we developed a drug delivery system incorporating PTX onto polyethylene glycol (PEG)-modified and oxidized sodium alginate (OSA) -functionalized graphene oxide (GO) nanosheets (NSs), called PTX@GO-PEG-OSA. Owing to pH/thermal-sensitive drug release properties, PTX@GO-PEG-OSAcould induced more obvious antitumor effects on GC, compared to free PTX. With near infrared (NIR)-irradiation, PTX@GO-PEG-OSA could generate excessive reactive oxygen species (ROS), attack mitochondrial respiratory chain complex enzyme, reduce adenosine-triphosphate (ATP) supplement for Pgp, and effectively inhibit P-gp’s efflux pump function. Since that, PTX@GO-PEG-OSA achieved better therapeutic effect on PTX-resistant GC without evident toxicity (Scheme 1).
Conclusions
In conclusion, PTX@GO-PEG-OSA could serve as a desirable strategy to reverse PTX’s resistance, combined with chemo/photothermal/photodynamic therapy.
關鍵詞:Graphene oxide (GO), drug resistance, P-glycoprotein (P-gp), chemo/photothermal (PTT)/photodynamic (PDT) therapy, mitochondrial respiratory chain
免責聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡有限公司-化工儀器網(wǎng)合法擁有版權或有權使用的作品,未經本網(wǎng)授權不得轉載、摘編或利用其它方式使用上述作品。已經本網(wǎng)授權使用作品的,應在授權范圍內使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關法律責任。
- 本網(wǎng)轉載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉載時,必須保留本網(wǎng)注明的作品第一來源,并自負版權等法律責任。
- 如涉及作品內容、版權等問題,請在作品發(fā)表之日起一周內與本網(wǎng)聯(lián)系,否則視為放棄相關權利。